FONOTIPO: Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05955794
Collaborator
University of Florence (Other), Campus Bio-Medico University (Other)
500
1
2
24
20.8

Study Details

Study Description

Brief Summary

Primary Study Objective The primary objective of the study is the definition of distinct vocal phenotypes and the development of an Explained Decision Support System (DSS) for the automatic detection of vocal patterns in relation to the syndrome from which the patients suffer

Secondary:
  1. Perceptual and acoustic analysis of voice recordings

  2. Development of a voice recording collection system.

Condition or Disease Intervention/Treatment Phase
  • Other: voice recordings
N/A

Detailed Description

Genetic syndromes have been extensively studied and numerous research studies have enabled a better definition of their clinical manifestations, natural history and aetiopathogenetic mechanisms. In these multisystem conditions, some relevant but as yet unexplored aspects need to be clarified, and one of these aspects is the characterisation of vocal production. To date, more than 240 genetic syndromes have distinctive voice quality abnormalities that are significant enough to be considered diagnostic indicators. However, with the exception of Down syndromes, X-fragile, Williams and velocardiofacial syndromes, no scientific studies focusing on vocal analysis have been conducted on patients with genetic syndromes in order to obtain a complete and objective characterisation of vocal characteristics.

Due to the sophisticated human auditory apparatus, perceptual analysis is the basic approach for assessing voice quality. However, an objective assessment of voice quality is crucial in order to minimise errors due to perceptual and, consequently, individual analysis. Currently, the most widely used tool by researchers is Praat, although its use, being not very intuitive, can be challenging for those with little computer experience. Consequently, the use of the default settings (adult male voice) may give somewhat misleading results. To partially overcome some of the above-mentioned problems, a new user-friendly software called Biovoice has recently been developed. Recently, a number of new measurement methods have been designed to assess vocal characteristics, mainly based on the theory of non-linear dynamic systems . This theory is supported by extensive modelling studies and evidence that vocal production is a highly non-linear dynamical system, in which changes caused by alterations in the vocal organs, muscles and nerves affect the dynamics of the whole system. Consequently, these changes can be detected by means of non-linear time series analysis tools or by means of computational approaches based on artificial intelligence. This project starts from the consideration that certain genetic abnormalities that cause a specific recognisable phenotype could also result in a specific vocal phenotype, or rather a 'phonotype'. Since vocal assessment is based on non-invasive and easily administered tests, vocal characterisation could be an informative tool in the diagnostic process and help both in defining the severity of clinical pictures and in performing genotype/phenotype correlations. Furthermore, voice studies could detect and monitor the progression of symptoms in certain genetic conditions that are often characterised by a regressive trend, such as in neuromuscular or metabolic syndromes. Smartphone technology, which has already been implemented in other fields, such as in dysphonia and Parkinson's disease, can be used to collect voice recordings of syndromic patients and can be an important tool to implement computerised assessment. Unlike most smartphone-based voice analysis tools, special attention will be paid to the reliability of audio recordings, both in the laboratory and at home, which will be performed according to a strict protocol. This will allow for uniform and reliable data and results. Artificial intelligence techniques will play a key role in studying the role of voice characterisation in diagnostic work for genetic syndromes. In addition, speech analysis could support the evaluation of the effectiveness of speech therapy, drug treatment and other rehabilitation approaches.

Primary Study Objective:

The primary objective of the study is the definition of distinct vocal phenotypes and the development of an Explained Decision Support System (DSS) for the automatic detection of vocal patterns in relation to the syndrome from which the patients suffer

Secondary:
  1. Perceptual and acoustic analysis of voice recordings

  2. Development of a voice recording collection system.

Number of participants: 500 (400 syndromic patients plus 100 non-syndromic controls matched by gender and age).

400 patients suffering from different syndromes will be recruited, although the investigators will focus in particular on Down syndrome, Noonan, Costello, Smith-Magenis, Cri du Chat, 22q11 deletion, Williams, Crisponi, Rubinstein Taybi and CHARGE to analyse their vocal pattern characteristics. The choice of the listed conditions is guided by their prevalence in the population and previously reported peculiar vocal patterns. The patients recruited are those regularly followed by the Centre for Rare Diseases and Congenital Defects of the Agostino Gemelli IRCCS University Polyclinic Foundation, Rome. Voice recordings collected in the laboratory from syndromic patients will be analysed both perceptually and objectively and compared with a control group of non-syndromic patients, matched for age and gender.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
500 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
participants: 500 (400 syndromic patients plus 100 non-syndromic controls matched for gender and age). 400 patients suffering from different syndromes will be recruited, although the investigators will focus in particular on Down syndrome, Noonan, Costello, Smith-Magenis, Cri du Chat, 22q11 deletion, Williams, Crisponi, Rubinstein Taybi and CHARGE to analyse their vocal pattern characteristics. The choice of the listed conditions is guided by their prevalence in the population and previously reported peculiar vocal patterns. The patients recruited are those regularly followed by the Centre for Rare Diseases and Congenital Defects of the Agostino Gemelli IRCCS University Polyclinic Foundation, Rome. Voice recordings collected in the laboratory from syndromic patients will be analysed both perceptually and objectively and compared with a control group of non-syndromic patients, matched for age and gender.participants: 500 (400 syndromic patients plus 100 non-syndromic controls matched for gender and age). 400 patients suffering from different syndromes will be recruited, although the investigators will focus in particular on Down syndrome, Noonan, Costello, Smith-Magenis, Cri du Chat, 22q11 deletion, Williams, Crisponi, Rubinstein Taybi and CHARGE to analyse their vocal pattern characteristics. The choice of the listed conditions is guided by their prevalence in the population and previously reported peculiar vocal patterns. The patients recruited are those regularly followed by the Centre for Rare Diseases and Congenital Defects of the Agostino Gemelli IRCCS University Polyclinic Foundation, Rome. Voice recordings collected in the laboratory from syndromic patients will be analysed both perceptually and objectively and compared with a control group of non-syndromic patients, matched for age and gender.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes
Anticipated Study Start Date :
Jul 20, 2023
Anticipated Primary Completion Date :
May 15, 2025
Anticipated Study Completion Date :
Jul 20, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: patient group

500 (400 syndromic patients plus 100 non-syndromic controls matched for gender and age)

Other: voice recordings
Experimental treatment/procedure: The first recording will be made in the laboratory. The lab will have sound insulation (the sound-to-noise ratio of the room should be at least 30dB) to record the voice samples. Similar to the recordings made in the lab, parents/caregivers will be instructed on how to collect voice recordings at home several times during the day using a smartphone. Parents/caregivers will be asked to note down the patient's emotional state during each recording in a predefined protocol. All patients will undergo paediatric, morphological, neurocognitive and behavioural assessment, hearing and ENT evaluation, perceptual and acoustic voice analysis. Perceptual assessment will be done blind.The vowel recordings will be analysed by two software tools: Biovoice [1] and Praat [2].

Other: control group

500 (400 syndromic patients plus 100 non-syndromic controls matched for gender and age)

Other: voice recordings
Experimental treatment/procedure: The first recording will be made in the laboratory. The lab will have sound insulation (the sound-to-noise ratio of the room should be at least 30dB) to record the voice samples. Similar to the recordings made in the lab, parents/caregivers will be instructed on how to collect voice recordings at home several times during the day using a smartphone. Parents/caregivers will be asked to note down the patient's emotional state during each recording in a predefined protocol. All patients will undergo paediatric, morphological, neurocognitive and behavioural assessment, hearing and ENT evaluation, perceptual and acoustic voice analysis. Perceptual assessment will be done blind.The vowel recordings will be analysed by two software tools: Biovoice [1] and Praat [2].

Outcome Measures

Primary Outcome Measures

  1. Vocal Phenotype definition of frequencies [2 years]

    Distinct vocal phenotypes of each syndrome will be extracted through Biovoice software. BioVoice allows the sequential analysis of several audio signals at once without any manual setting. The software allows the analysis of fundamental and formants frequency (measured in Hz).

  2. Vocal Phenotype definition of irregularity [2 years]

    The definition of irregularity of voices of each syndrome will be extracted through PRAAT software. PRAAT implements a method based on autocorrelation, applied to a time window of fixed size, and linear predictive coding. It requires the manual setting of some parameters. The software allows the analysis of irregularity, namely jitter that is the relative average perturbation (measured in absolute jitter =1N-1∑i=1N-1|Ti-Ti+1|).

  3. Vocal Phenotype definition of noise [2 years]

    The definition of irregularity of voices of each syndrome will be extracted through PRAAT software. PRAAT implements a method based on autocorrelation, applied to a time window of fixed size, and linear predictive coding. It requires the manual setting of some parameters. The software allows the analysis of noise (measured in dB).

Secondary Outcome Measures

  1. Perceptual and acoustic analysis of voice recordings [2 years]

    The perceptual evaluation of voice is aimed at further delineate the differences between syndromic and healthy subject voices. Judges will score the voice of each participant using the Grade, Instability, Roughness, Breathiness, Asthenia, and Strain (GIRBAS) scale. GIRBAS scale provides a perceptual evaluation of voice according to five parameters: Grade (overall impression), Roughness, Breathiness, Asthenicity and Strain. Each parameter is rated on a 0 to 3 scale, where 0 indicates normality; 1, a slight deviance; 2, a moderate deviance; and 3, a severe deviance from normal.

  2. Other perceptual and acoustic analysis of voice recordings [2 years]

    Hypernasality and hyponasality will be assessed using a 4-point ordinal rating scale with 1 representing normal resonance, 2, 3, and 4 representing mild, moderate and severe impairment.

  3. Development of a system for collecting voice recordings - frequencies [2 years]

    The development of a system to collect voice recordings will be made throught a Structured Query Language (SQL) database where all the voice recordings obtained will be stored in encrypted hard disks, accessible for data analysis and storage. For this project a cross-platform app, to record and manage the voice signal, for smartphones will be developed through an app framework (e.g Xamarin). The following acoustic parameters will be stored and managed: fundamental and formants frequency (measured in Hz).

  4. Development of a system for collecting voice recordings - irregularities [2 years]

    The development of a system to collect voice recordings will be made throught a Structured Query Language (SQL) database where all the voice recordings obtained will be stored in encrypted hard disks, accessible for data analysis and storage. For this project a cross-platform app, to record and manage the voice signal, for smartphones will be developed through an app framework (e.g Xamarin). The following acoustic parameters will be stored and managed: relative average perturbation (measured in absolute jitter).

  5. Development of a system for collecting voice recordings - noise [2 years]

    The development of a system to collect voice recordings will be made throught a Structured Query Language (SQL) database where all the voice recordings obtained will be stored in encrypted hard disks, accessible for data analysis and storage. For this project a cross-platform app, to record and manage the voice signal, for smartphones will be developed through an app framework (e.g Xamarin). The following acoustic parameters will be stored and managed: noise (measured in dB).

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Laboratory confirmation of the clinical diagnosis of one of the syndromes under investigation.

  • Informed consent from parents, legal representatives or the patients themselves, according to the instructions of the hospital's Ethics Committee.

Exclusion Criteria:
  • Concomitant acute inflammatory disease of the upper respiratory tract.

  • Refusal to sign the informed consent to participate in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione Policlinico Universitario A. Gemelli Irccs Roma Italy 00168

Sponsors and Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • University of Florence
  • Campus Bio-Medico University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zampino Giuseppe, professor, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT05955794
Other Study ID Numbers:
  • 5802
First Posted:
Jul 21, 2023
Last Update Posted:
Jul 21, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2023